Recurrent Disease Active Not Recruiting Phase 2 Trials for Dasatinib (DB01254)

IndicationStatusPhase
DBCOND0028541 (Recurrent Disease)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs